EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Scaling up Genomics

Kushani Jayasinghe, Rigan Tytherleigh, Stephanie Best, Simon Bodek, Paula Bussa, Grainne Butler, Ainsley Campbell, Amy Clarke, Brendan Cusack, Elizabeth Donaldson, Yoni Elbaum, Clara Gaff, Russell Gear, Asheeta Gupta, Paul James, Lilian Johnstone, Peter G. Kerr, Emma Krzesinski, Anna Leaver, Benjamin Lazarus, Mandy Law, Po Yee Mia Leung, Sebastian Lunke, Melissa Martyn, Briannah Miles, Kathleen Nicholls, Lokman Pang, Matthew Regan, Jessica Ryan, Judy Savige, Bryony Thompson, Alison Trainer, Giulia Valente, Kathryn Visser, Andrea Ward, Jack Wheeler, John Whitlam, Ella J. Wilkins, Ingrid Winship, Kenneth Xie

Clinical Journal of the American Society of Nephrology · 2026-11 · 21 (11) · 1968-1980

DOI: 10.2215/cjn.0000001184 ↗
AbstractBibliografische Angaben

Abstract

Key Points We evaluated a hub and spoke mainstreaming model to enable nephrologists to order genomic tests independently in their clinic across the state of Victoria. Over 1000 tests were ordered, with the diagnostic yield remaining similar regardless of ordered by local nephrologists or tertiary genomics services. A mainstreaming model proved feasible, scalable, and clinically effective, offering a practical framework for integrating genomics to routine kidney care. Background Genomic testing has substantial diagnostic and clinical value in nephrology, yet integrating testing into routine care requires service-level changes to ensure timely and equitable access. Methods We conducted an observational cohort study at four tertiary centers, with a pragmatic, quasi-experimental design to evaluate evidence-informed, service-level interventions to make genomic testing more accessible and routinely embedded within nephrology practice. We implemented a hub and spoke model which provided nephrologists with training, practical resources, and regular case-based discussions, to support test ordering and interpretation within their own clinics. Laboratory audits (June 2021–July 2024) evaluated how public reimbursement and implementation interventions influenced testing patterns. Three periods were compared: prefunding, postfunding, and postintervention. Results Across the study period, 1028 genomic tests were ordered (63% adults, 37% children; median age 32 years). Results were available for 1014 tests, with an overall diagnostic yield of 34%, which remained stable across all time points. The diagnostic yield was similar regardless of whether testing occurred at tertiary genomics services (249 of 772, 32%) or via local nephrologists (92 of 242, 38%). The number of unique providers ordering tests was higher (T1: 37, T2: 69, T3: 87). The proportion of testing in mainstream nephrology settings rose from 23% to 74%, while absolute testing numbers in multidisciplinary clinics remained consistent over the study period. Conclusion Mainstreaming genomic testing in nephrology was feasible, scalable, and clinically effective. This model was associated with better access without compromising diagnostic yield and provides a practical framework for integrating genomic medicine into routine kidney care.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →